$98.86
-9.03-8.37%
At close: -
$99.99
1.131.14%
After Hours: 4:55 PM EDT
Comments
Loading...
Axsome Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:AXSM | Benzinga
Axsome Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$-0.870
Quarterly Revenue Estimate
$121.46M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$385.69M
Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics | -$1.00 | -$0.87 | — | — | $75.00M | $121.46M | — | — | 05/05/2025 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.73 | -$0.99 | -$0.80 | 19.19% | $71.53M | $117.83M | $118.77M | 0.79% | 02/18/2025 | Get Alert |
| AXSM | Axsome Therapeutics | -$1.32 | -$1.41 | -$0.49 | 65.25% | $57.79M | $98.10M | $104.76M | 6.79% | 11/12/2024 | Get Alert |
| AXSM | Axsome Therapeutics | -$1.54 | -$1.33 | -$1.12 | 15.79% | $46.70M | $86.92M | $87.17M | 0.28% | 08/05/2024 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.26 | -$1.21 | -$1.00 | 17.36% | $94.58M | $73.47M | $75.00M | 2.08% | 05/06/2024 | Get Alert |
| AXSM | Axsome Therapeutics | -$1.41 | -$1.15 | -$0.73 | 36.52% | $24.37M | $67.69M | $71.53M | 5.67% | 02/20/2024 | Get Alert |
| AXSM | Axsome Therapeutics | -$1.07 | -$1.19 | -$1.32 | -10.92% | $16.85M | $55.75M | $57.79M | 3.67% | 11/06/2023 | Get Alert |
| AXSM | Axsome Therapeutics | -$1.06 | -$1.24 | -$1.54 | -24.19% | $8.82M | $40.19M | $46.70M | 16.20% | 08/07/2023 | Get Alert |
| AXSM | Axsome Therapeutics | -$1.03 | -$1.04 | -$0.26 | 75.00% | $0.00 | $26.07M | $94.58M | 262.78% | 05/08/2023 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.90 | -$1.14 | -$1.41 | -23.68% | $0.00 | $21.76M | $24.37M | 12.00% | 02/27/2023 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.93 | -$1.08 | -$1.07 | 0.93% | $0.00 | $17.53M | $16.85M | -3.90% | 11/07/2022 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.86 | -$1.24 | -$1.06 | 14.52% | $0.00 | $6.29M | $8.82M | 40.22% | 08/09/2022 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.78 | -$1.00 | -$1.03 | -3.00% | $0.00 | — | $0.00 | — | 05/02/2022 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.78 | -$1.03 | -$0.90 | 12.62% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.61 | -$0.95 | -$0.93 | 2.11% | $0.00 | — | $0.00 | — | 11/08/2021 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.49 | -$0.97 | -$0.86 | 11.34% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.88 | -$0.87 | -$0.78 | 10.34% | $0.00 | — | $0.00 | — | 05/10/2021 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.71 | -$0.76 | -$0.78 | -2.63% | $0.00 | — | $0.00 | — | 03/01/2021 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.56 | -$0.57 | -$0.61 | -7.02% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.41 | -$0.62 | -$0.49 | 20.97% | $0.00 | — | $0.00 | — | 08/10/2020 | Get Alert |
| AXSM | Axsome Therapeutics | -$0.32 | -$0.62 | -$0.88 | -41.94% | $0.00 | — | $0.00 | — | 05/08/2020 | Get Alert |
Axsome Therapeutics (AXSM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-18 | $-0.80 | $-0.99 | 19.2 % |
| Q3 | 2024-11-12 | $-0.49 | $-1.41 | 65.3 % |
| Q2 | 2024-08-05 | $-1.12 | $-1.33 | 15.8 % |
| Q1 | 2024-05-06 | $-1.00 | $-1.21 | 17.4 % |
Axsome Therapeutics (AXSM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-18 | $118.77M | $117.83M | 0.79 % |
| Q3 | 2024-11-12 | $104.76M | $98.10M | 6.79 % |
| Q2 | 2024-08-05 | $87.17M | $86.92M | 0.28 % |
| Q1 | 2024-05-06 | $75.00M | $73.47M | 2.08 % |
FAQ
When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?
Axsome Therapeutics (AXSM) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 18, 2025 for Q4.
What were the latest earnings per share (EPS) for Axsome Therapeutics (NASDAQ:AXSM)?
The Actual EPS was $-0.80, which beat the estimate of $-0.99.
What were Axsome Therapeutics’s (NASDAQ:AXSM) revenues?
The Actual Revenue was $118.8M, which beat the estimate of $117.8M.
Browse earnings estimates, EPS, and revenue on all stocks.